Chemotherapy-induced nausea and vomiting can severely impact patients’ quality of life and treatment adherence. In a major clinical trial, researchers from Japan tested whether a low, 5 mg dose of olanzapine taken at home after chemotherapy could reduce these side effects without causing heavy sedation. The study found that this approach significantly improved outcomes compared to placebo, offering a safer, more affordable strategy that could reshape supportive cancer care, especially in outpatient and resource-limited settings.

A first-of-its-kind study, led by LaShae Rolle, a 27 y/o breast cancer researcher, survivor and elite powerlifter, challenges the long-held belief that cancer patients should stick to low- or moderate exercise and suggests that with individualized and symptom-informed exercise planning, even powerlifting can be safe and beneficial.